Skip to main content
logo
Fennec Pharmaceuticals Inc. (FENC)
NASDAQ: FENC · Real-Time Price · USD
9.93
+0.04 (0.40%)
May 29, 2026, 4:00 PM EDT - Market closed

Fennec Pharmaceuticals Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
5144.6447.5421.251.54-
Revenue Growth (YoY)
64.98%-6.09%123.69%1284.50%--
Cost of Revenue
3.963.763.181.26-0.09-
Gross Profit
47.0440.8844.3519.991.62-
Selling, General & Admin
52.8946.9141.4832.7120.5112.24
Research & Development
0.210.250.310.063.534.98
Total Operating Expenses
53.0947.1641.7932.7624.0417.22
Operating Income
-6.06-6.282.57-12.77-22.59-17.22
Interest Income
0.890.791.680.440.20.05
Interest Expense
-1.5-2.08-4.07-3.39-0.98-0.13
Other Non-Operating Income (Expense)
-2.07-2.06-0.25-0.32-0.34-0.05
Total Non-Operating Income (Expense)
-2.68-3.35-2.64-3.27-1.13-0.12
Pretax Income
-5.14-9.64-0.07-16.05-23.71-17.35
Provision for Income Taxes
-0.110.37---
Net Income
-8.73-9.74-0.44-16.05-23.71-17.35
Net Income to Common
-8.73-9.74-0.44-16.05-23.71-17.35
Shares Outstanding (Basic)
302927272626
Shares Outstanding (Diluted)
312927272626
Shares Change (YoY)
11.46%4.70%2.71%1.14%1.03%9.71%
EPS (Basic)
-0.29-0.34-0.02-0.60-0.90-0.67
EPS (Diluted)
-0.29-0.34-0.02-0.60-0.90-0.67
Shares Outstanding
0.0334.1627.5326.3626.2826.01
Free Cash Flow
-5.78-12.4726.98-17.14-18.06-14.22
Free Cash Flow Per Share
-0.19-0.440.99-0.65-0.69-0.55
Gross Margin
92.23%91.57%93.30%94.08%105.60%-
Operating Margin
-11.87%-14.07%5.40%-60.09%-1471.60%-
Profit Margin
-10.09%-21.82%-0.92%-75.50%-1544.89%-
FCF Margin
-11.33%-27.94%56.75%-80.67%-1176.42%-
EBITDA
-6.06-6.282.57-12.77-22.59-17.22
EBIT
-6.06-6.282.57-12.77-22.59-17.22
EBIT Margin
-11.87%-14.07%5.40%-60.09%-1471.60%-
Effective Tax Rate
--1.10%-514.09%0.00%0.00%0.00%
SEC Filings: 10-K · 10-Q